Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Brilacidin, a host defense peptide mimetic, potentiates ibrexafungerp antifungal activity against the human pathogenic fungus Aspergillus fumigatus

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.05.588305Source: DataRank Database

Brilacidin, a host defense peptide mimetic, potentiates ibrexafungerp antifungal activity against the human pathogenic fungus Aspergillus fumigatus is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (31)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Camila Diehl ORCID,Camila Figueiredo Pinzan ORCID,Patrícia Alves de Castro ORCID,Gustavo H. Goldman ORCID,Thaila Fernanda dos Reis ORCID

Live enrichment

PubMed:38617338 OpenAlex:https://openalex.org/W4394061609

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R01AI153356-04

Deciphering the phenotypic and genomic traits that underlie the evolution of pathogenicity differences among Aspergillus fumigatus and its close relatives

NIAID NIH HHS

Grant: R01 AI153356

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2024/04/07/2024.04.05.588305.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2024.04.05.588305

repositoryhttp://dx.doi.org/10.1101/2024.04.05.588305

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38617338

Fields of Study

Antifungal resistance and susceptibilityAntimicrobial Peptides and ActivitiesPeptidase Inhibition and Analysis0301 basic medicine03 medical and health sciences

Keywords

Aspergillus fumigatusMicrobiologyFungusAntifungalAspergillosisAspergillusPeptidePathogenic fungusBiologyChemistryBiochemistryImmunologyBotanydrug resistanceAntifungal AgentsbrilacidinibrexafungerpObservationDrug SynergismMicrobial Sensitivity TestsQR1-502ArticleA549 CellsDrug Resistance, FungalHumansAntimicrobial Peptides

Sustainable Development Goals

SDG 3: 3. Good health